| P50 | author | Marcelo E Bigal | Q78653335 |
| P2093 | author name string | Carla da Cunha Jevoux | |
| | Abouch Valenty Krymchantowski | |
| P2860 | cites work | Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology | Q28138991 |
| | A comment on acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial | Q28195316 |
| | OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program | Q34116531 |
| | Migraine--current understanding and treatment | Q34504002 |
| | Chronic disorders with episodic manifestations: focus on epilepsy and migraine | Q34590975 |
| | Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine | Q34593878 |
| | The global burden of headache: a documentation of headache prevalence and disability worldwide | Q34611721 |
| | Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. | Q51948254 |
| | Validation of a New Quality of Life Questionnaire for Acute Migraine Headache | Q53642905 |
| | Testing the combination beta-blocker plus topiramate in refractory migraine | Q79525419 |
| | Clinical practice guidelines | Q81214651 |
| | Treatment of migraine with prophylactic drugs | Q94706718 |
| | Sumatriptan-naproxen for acute treatment of migraine: a randomized trial | Q34615293 |
| | Why headache treatment fails | Q35101920 |
| | Migraine preventive therapy: current and emerging treatment options | Q36145412 |
| | Migraine: barriers for care | Q36145435 |
| | Effect of preventive treatment on health-related quality of life in episodic migraine | Q36260569 |
| | Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size | Q36264929 |
| | Polytherapy in the preventive and acute treatment of migraine: fundamentals for changing the approach | Q36419543 |
| | Migraine prevention trials and optimized acute therapy: translating lessons learned into clinical practice | Q37270897 |
| | Barriers to satisfactory migraine outcomes. What have we learned, where do we stand? | Q37457145 |
| | Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes | Q39335482 |
| | Migraine. Identifying and removing barriers to care. | Q40659337 |
| | Migraine prevalence, disease burden, and the need for preventive therapy | Q43983035 |
| | The impact of topiramate on health-related quality of life indicators in chronic migraine | Q46871329 |
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | 53-59 | |
| P577 | publication date | 2011-10-19 | |
| P1433 | published in | The journal of headache and pain : official journal of the Italian Society for the Study of Headaches | Q26842211 |
| P1476 | title | Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders | |
| P478 | volume | 13 | |